RHEP on OTC
REGIONAL HEALTH PROPERTIES, INC
Lessors of Real Property company, listed on OTC (RHEP).
Price unavailable
Last updated Oct 18, 2026.
Overview
Compare with Alico, Star Holdings or GLADSTONE COMMERCIAL CORP, or pick any stock.
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
3.1%Operating margin3
6.3%Net margin3
189.9%Revenue growth, 20253
965.6%Return on equity3
99.54×Debt to equity3
-$3.1MFree cash flow3
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Health Care, Patient Service brought in 68% of the revenue REGIONAL HEALTH PROPERTIES, INC broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2024 | 2025 |
|---|---|---|
| Health Care, Patient Service | $11.3M | $36.0M |
| Pharmacy Revenues | $11.7M | |
| Rental Revenue | $7.0M | $5.4M |
Business segments
Healthcare Services brought in 68% of the revenue REGIONAL HEALTH PROPERTIES, INC broke down this way in fiscal 2025.
Business segments by year
| Business segments | 2024 | 2025 |
|---|---|---|
| Healthcare Services | $11.3M | $36.0M |
| Pharmacy Service | $11.7M | |
| Real Estate | $7.1M | $5.4M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue13¢$7.0M
- Other costs80¢$42.7M
- Income tax0¢$108.0K
- Profit6¢$3.4M
Out of $53.2M in revenue.3
Financial statements
Every line of the income statement as filed: the last 2 fiscal years, latest first.3
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Total revenues | $53.2M | $18.3M |
| Cost of goods sold | $7.0M | |
| Patient care expense | $30.8M | $9.4M |
| Facility rent expense | $780.0K | $594.0K |
| Depreciation and amortization | $2.1M | $2.1M |
| General and administrative expense | $12.0M | $5.4M |
| Loss on lease termination | $862.0K | |
| Credit loss expense | $795.0K | $668.0K |
| Gain on operations transfer | -$106.0K | |
| Total expenses | $54.2M | $18.2M |
| Gain on asset sale | -$2.7M | |
| Income from operations | $1.7M | $161.0K |
| Interest expense, net | $2.7M | $2.7M |
| Gain on bargain purchase | -$5.8M | |
| Other expense, net | $1.4M | $669.0K |
| Total other (income) expense, net | -$1.7M | $3.4M |
| Net income (loss) | $3.4M | -$3.2M |
| Preferred stock dividends | -$603.0K | |
| Deemed contribution related to Preferred Series B purchases | $278.0K | |
| Net profit (loss) attributable to Regional Health Properties, Inc. common stockholders | $3.0M | -$3.2M |
| Unrecognized net gain on pension assets | $22.0K | |
| Comprehensive income | $3.1M | -$3.2M |
| Net profit (loss) per share of common stock attributable to Regional Health Properties, Inc.:, basic | $1.09 | -$1.73 |
| Net profit (loss) per share of common stock attributable to Regional Health Properties, Inc.:, diluted | $1.09 | -$1.73 |
| Basic (in shares) | 2.8K shares | 1.9K shares |
| Diluted (in shares) | 2.8K shares | 1.9K shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.3
| Period ending | 2025-12-31 | 2025-01-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|---|
| Cash | $3.0M | $582.0K | ||
| Restricted cash | $1.6M | $1.9M | ||
| Accounts receivable, net of allowances of $727 and $141 | $8.0M | $3.4M | $1.4M | |
| Inventory | $1.4M | |||
| Notes receivable | $644.0K | $369.0K | ||
| Prepaid expenses and other | $1.6M | $633.0K | ||
| Total current assets | $16.3M | $6.8M | ||
| Property and equipment, net | $35.8M | $33.5M | ||
| Assets held for sale, net | $4.2M | $10.3M | ||
| Restricted cash | $1.4M | $1.0M | ||
| Intangible assets | $4.7M | $2.5M | ||
| Other assets | $3.8M | $4.7M | ||
| Goodwill | $1.6M | $1.6M | ||
| Total assets | $67.8M | $60.5M | ||
| Accounts payable | $7.0M | $3.7M | ||
| Accrued expenses | $7.9M | $5.4M | ||
| Other liabilities | $867.0K | $865.0K | ||
| Debt related to assets held for sale, net | $3.0M | $8.2M | ||
| Current portion of long term debt | $5.4M | $2.2M | ||
| Total current liabilities | $24.2M | $20.4M | ||
| Long-term debt, net - less current maturities | $34.7M | $39.3M | ||
| Operating lease obligation | $2.3M | $2.0M | ||
| Other liabilities | $1.6M | $1.7M | ||
| Total liabilities | $62.8M | $63.4M | ||
| Common stock and additional paid-in capital, no par value; 55,000 shares authorized; 3,946 and 1,890 shares issued and 3,935 and 1,879 shares outstanding at December 31, 2025 and December 31, 2024, respectively | $67.3M | $63.2M | ||
| Accumulated deficit | -$81.8M | -$85.1M | ||
| Accumulated other comprehensive earnings | $22.0K | |||
| Total stockholders' equity (deficit) | $349.0K | -$2.9M | ||
| Total liabilities, Series D preferred stock and stockholders' equity (deficit) | $67.8M | $60.5M | ||
| Accounts receivable, allowances | $727.0K | $141.0K | ||
| Common stock and additional paid-in capital, par value | $0 | $0 | ||
| Common stock and additional paid-in capital, shares authorized | 55.0M shares | 55.0M shares | ||
| Common stock and additional paid-in capital, shares issued | 3.9M shares | 250.0K shares | 1.9M shares | |
| Common stock and additional paid-in capital, shares outstanding | 3.9M shares | 1.9M shares |
| Period ending | 2025-12-31 | 2025-01-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|---|
| Cash | $3.0M | $582.0K | ||
| Restricted cash | $1.6M | $1.9M | ||
| Accounts receivable, net of allowances of $727 and $141 | $8.0M | $3.4M | $1.4M | |
| Inventory | $1.4M | |||
| Notes receivable | $644.0K | $369.0K | ||
| Prepaid expenses and other | $1.6M | $633.0K | ||
| Total current assets | $16.3M | $6.8M | ||
| Property and equipment, net | $35.8M | $33.5M | ||
| Assets held for sale, net | $4.2M | $10.3M | ||
| Restricted cash | $1.4M | $1.0M | ||
| Intangible assets | $4.7M | $2.5M | ||
| Other assets | $3.8M | $4.7M | ||
| Goodwill | $1.6M | $1.6M | ||
| Total assets | $67.8M | $60.5M | ||
| Accounts payable | $7.0M | $3.7M | ||
| Accrued expenses | $7.9M | $5.4M | ||
| Other liabilities | $867.0K | $865.0K | ||
| Debt related to assets held for sale, net | $3.0M | $8.2M | ||
| Current portion of long term debt | $5.4M | $2.2M | ||
| Total current liabilities | $24.2M | $20.4M | ||
| Long-term debt, net - less current maturities | $34.7M | $39.3M | ||
| Operating lease obligation | $2.3M | $2.0M | ||
| Other liabilities | $1.6M | $1.7M | ||
| Total liabilities | $62.8M | $63.4M | ||
| Common stock and additional paid-in capital, no par value; 55,000 shares authorized; 3,946 and 1,890 shares issued and 3,935 and 1,879 shares outstanding at December 31, 2025 and December 31, 2024, respectively | $67.3M | $63.2M | ||
| Accumulated deficit | -$81.8M | -$85.1M | ||
| Accumulated other comprehensive earnings | $22.0K | |||
| Total stockholders' equity (deficit) | $349.0K | -$2.9M | ||
| Total liabilities, Series D preferred stock and stockholders' equity (deficit) | $67.8M | $60.5M | ||
| Accounts receivable, allowances | $727.0K | $141.0K | ||
| Common stock and additional paid-in capital, par value | $0 | $0 | ||
| Common stock and additional paid-in capital, shares authorized | 55.0M shares | 55.0M shares | ||
| Common stock and additional paid-in capital, shares issued | 3.9M shares | 250.0K shares | 1.9M shares | |
| Common stock and additional paid-in capital, shares outstanding | 3.9M shares | 1.9M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.3
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net income (loss) | $3.4M | -$3.2M |
| Depreciation and amortization | $2.1M | $2.1M |
| Gain on bargain purchase | -$5.8M | |
| Stock-based compensation expense | $233.0K | $114.0K |
| Rent expense less than cash paid | -$385.0K | -$44.0K |
| Rent revenue in excess of cash received | $788.0K | -$535.0K |
| Amortization of deferred financing costs, debt discounts and premiums | $173.0K | $74.0K |
| Gain on asset sale | -$2.7M | |
| Gain on operations transfer | -$106.0K | |
| Loss on lease termination | $862.0K | |
| Pension benefit adjustment | $22.0K | |
| Credit loss expense | $795.0K | $668.0K |
| Change in inventory | -$42.0K | |
| Accounts receivable | -$3.6M | -$1.7M |
| Prepaid expenses and other assets | -$730.0K | $1.7M |
| Accounts payable and accrued expenses | $2.9M | $2.6M |
| Other liabilities | -$162.0K | $292.0K |
| Net cash (used in) provided by operating activities | -$2.3M | $1.9M |
| Proceeds from the sale of property and equipment, net | $10.0M | |
| Cash acquired from merger | $6.0M | |
| Purchase of property and equipment | -$869.0K | -$530.0K |
| Net cash provided by (used in) investing activities | $15.1M | -$530.0K |
| Payment of senior debt | -$1.8M | -$1.4M |
| Payment of other debt | -$1.1M | -$1.2M |
| Payoff of debt for asset held for sale | -$5.2M | |
| Repurchase of Preferred B Shares | -$3.6M | |
| Proceeds from the exercise of stock options | $129.0K | |
| Proceeds from other debt | $1.4M | $430.0K |
| Net cash used in financing activities | -$10.2M | -$2.1M |
| Net change in cash and restricted cash | $2.6M | -$712.0K |
| Cash interest paid | $2.5M | $2.7M |
| Vendor-financed insurance | $836.0K | $1.0M |
| Building improvements financed with note payable | $126.0K | |
| Preferred stock dividends paid in common stock | $603.0K | |
| Issuance of Series D Preferred Shares | $4.7M | |
| Common shares issued for merger | $3.2M |
No quarter-by-quarter statement was filed.
Compare REGIONAL HEALTH PROPERTIES, INC with another company
Leadership
Who has led REGIONAL HEALTH PROPERTIES, INC, and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
Chief operating officer
2010201520202025
- Chief executive officerBrent Morrison Apr 26, 2018 to now12
- Chief executive officerDavid A. Tenwick Jul 3, 2014 to Jul 3, 201413
- Chief executive officerBoyd P. Gentry Jun 6, 2011 to Nov 14, 201314
- Chief executive officerSharon L. Reynolds Apr 11, 2007 to Apr 11, 200715
- Chief executive officerGary L. Wade Dec 27, 2006 to Feb 15, 201116
- ChairDavid A. Tenwick Dec 27, 2006 to Jun 6, 201216
- PresidentBrent Morrison Jun 4, 2021 to now17
- PresidentAllan J. Rimland Apr 2, 2015 to Nov 30, 201618
- PresidentDavid A. Tenwick Jul 3, 2014 to Jul 3, 201413
- PresidentSharon L. Reynolds Apr 11, 2007 to Apr 11, 200715
- PresidentGary L. Wade Dec 27, 2006 to Feb 17, 201016
- Chief financial officerMarlie Davis May 7, 2026 to now19
- Chief financial officerMark J. Stockslager Aug 18, 2025 to May 7, 202620
- Chief financial officerBenjamin A. Waites Oct 7, 2020 to Feb 28, 202221
- Chief financial officerAllan J. Rimland Apr 2, 2015 to Nov 30, 201618
- Chief financial officerRonald W. Fleming May 17, 2013 to Sep 18, 201422
- Chief financial officerMartin D. Brew Jun 8, 2011 to Mar 22, 201223
- Chief financial officerJeffrey Scott Cunningham Dec 27, 2006 to Feb 14, 201116
- Chief operating officerClarence A. Shelton Iii. Sep 9, 2011 to Sep 9, 201124
- Chief operating officerClarence A. Peterson Apr 11, 2007 to Apr 11, 200725
- Chief operating officerPeter J. Hackett Apr 11, 2007 to Apr 11, 200726
- Chief operating officerLaurence E. Sturtz Dec 27, 2006 to Apr 11, 200727
Board members and other officers (27)
- EVP - Corporate StrategyRobert M. Thornton Jr. Aug 18, 2025 to now28
- Chief Accounting OfficerHeather L. Pittard Apr 26, 2024 to Apr 26, 202429
- Senior Vice PresidentPaul Jason O'Sullivan Apr 5, 2023 to now30
- Chief Accounting OfficerE. Clinton Cain Feb 9, 2016 to Feb 9, 201631
- VP Sales/Infant Products DivSusan I. Christensen Jun 15, 2015 to Jun 15, 201532
- Senior Vice PresidentClarence A. Shelton Iii. Aug 1, 2011 to Aug 1, 201133
- Chief Acquisition OfficerChristopher F. Brogdon Oct 6, 2011 to Nov 16, 201234
- OfficerGary L. Wade Apr 11, 2007 to Apr 11, 200715
- Sr Vice PresidentSharon L. Reynolds Dec 27, 2006 to Feb 15, 201116
- Board memberF. Scott Kellman Aug 18, 2025 to now35
- Board memberGene E. Burleson Aug 18, 2025 to now36
- Board memberSteven J. Baileys Aug 18, 2025 to now37
- Board memberC. Christian Winkle Aug 25, 2025 to now38
- Board memberSteven L. Martin Mar 17, 2023 to now39
- Board memberKenneth Wayne Taylor Feb 27, 2018 to now40
- Board memberBrian M. Szames May 3, 2017 to May 3, 201741
- Board memberThomas W. Knaup Oct 22, 2015 to Dec 20, 201642
- Board memberBrent Morrison Oct 22, 2014 to now43
- Board memberDavid A. Tenwick Feb 14, 2012 to Sep 1, 202144
- Board memberJoshua J. McClellan Feb 15, 2012 to Jun 6, 201245
- Board memberBoyd P. Gentry Jun 6, 2011 to Jan 14, 201314
- Board memberChristopher F. Brogdon Oct 29, 2009 to Nov 16, 201246
- Board memberClarence A. Peterson Dec 27, 2006 to Feb 21, 200847
- Board memberGary L. Wade Dec 27, 2006 to Feb 13, 201316
- Board memberLaurence E. Sturtz Dec 27, 2006 to Jan 21, 201516
- Board memberPeter J. Hackett Dec 27, 2006 to Dec 22, 201447
- Board memberPhilip S. Radcliffe Dec 27, 2006 to Jun 12, 201516
Former names
Timeline
- Apr 26, 2018New chief executive Brent Morrison becomes CEO12
- Jul 3, 2014New chief executive David A. Tenwick becomes CEO13
- Jun 6, 2011New chief executive Boyd P. Gentry becomes CEO14
- Apr 11, 2007New chief executive Sharon L. Reynolds becomes CEO15
- Dec 27, 2006New chief executive Gary L. Wade becomes CEO16
Filings
255 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 58 major events, 54 insider forms, 15 large holders, 108 other. The latest 20:
- Oct 2, 2026DEF 14A EDGAR
- Oct 1, 2026ARS EDGAR
- Aug 12, 202610-Q EDGAR
- Aug 4, 20264 OWNERSHIP DOCUMENT EDGAR
- Aug 4, 20263 OWNERSHIP DOCUMENT EDGAR
- Aug 4, 2026SCHEDULE 13G/A EDGAR
- Jun 8, 20264 EDGAR
- May 22, 20264 EDGAR
- May 15, 202610-Q EDGAR
- May 15, 2026SCHEDULE 13G/A EDGAR
- May 7, 20264 EDGAR
- May 7, 20263 EDGAR
- Apr 30, 20268-K EDGAR
- Apr 10, 20268-K EDGAR
- Apr 2, 202610-K EDGAR
- Mar 31, 2026NT 10-K EDGAR
- Mar 18, 20268-K EDGAR
- Mar 4, 20268-K EDGAR
- Feb 18, 2026SCHEDULE 13G/A EDGAR
- Feb 18, 2026SCHEDULE 13G EDGAR
The 255 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last three years, summarized. The full record is on SEC EDGAR.
Insider trades and holders
Large holders
Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 15 such filings since October 2021, the latest 10:
- Aug 4, 2026SCHEDULE 13G/A
- May 15, 2026SCHEDULE 13G/A
- Feb 18, 2026SCHEDULE 13G/A
- Feb 18, 2026SCHEDULE 13G
- Aug 21, 2025SCHEDULE 13D
- Aug 19, 2025SCHEDULE 13D
- Aug 12, 2025SCHEDULE 13D/A
- Jun 18, 2025SCHEDULE 13D/A
- Feb 25, 2025SCHEDULE 13D/A
- Feb 18, 2025SCHEDULE 13D/A
From Forms 4 and Schedules 13D and 13G filed with the SEC.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17SEC EDGARBrent Morrison, President
- 18SEC EDGARAllan J. Rimland, President
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35SEC EDGARF. Scott Kellman, Board member
- 36SEC EDGARGene E. Burleson, Board member
- 37SEC EDGARSteven J. Baileys, Board member
- 38SEC EDGARC. Christian Winkle, Board member
- 39SEC EDGARSteven L. Martin, Board member
- 40SEC EDGARKenneth Wayne Taylor, Board member
- 41SEC EDGARBrian M. Szames, Board member
- 42SEC EDGARThomas W. Knaup, Board member
- 43SEC EDGARBrent Morrison, Board member
- 44SEC EDGARDavid A. Tenwick, Board member
- 45SEC EDGARJoshua J. McClellan, Board member
- 46SEC EDGARChristopher F. Brogdon, Board member
- 47SEC EDGARClarence A. Peterson, Board member